Cargando…
Future prospects for cancer immunotherapy - Strategies for ineffective cancers
With the Nobel Prize in Physiology or Medicine in 2018, cancer immunotherapy is attracting more attention than ever before and is strongly expected to develop in the future. Immune checkpoint inhibitors were developed as drugs with a completely different mechanism from conventional chemotherapy for...
Autores principales: | Wada, Satoshi, Kobayashi, Shinichi, Tsunoda, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993051/ https://www.ncbi.nlm.nih.gov/pubmed/35077339 http://dx.doi.org/10.1080/21645515.2022.2031699 |
Ejemplares similares
-
Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015) -
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2022) -
Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
por: Lahoud, M. H., et al.
Publicado: (2021) -
IMMU-02. Targeted innovative antibody fragment-based immunotherapy for medulloblastoma
por: Niesen, Judith, et al.
Publicado: (2022) -
Oncolytic immunotherapy for metastatic cancer: lessons and future strategies
por: Guo, Zong-Sheng
Publicado: (2020)